Skip to main content

Table 1 Comparison of biallelic BRCA1 variant carriers regarding their genotype, phenotype, rescue mechanisms and classification of the detected variants1

From: Male with an apparently normal phenotype carrying a BRCA1 exon 20 duplication in trans to a BRCA1 frameshift variant

Study

Variant 1 (HGVS)

Variant 2 (HGVS)

Physical phenotype

(onset age in years)

Chromosome breakage

Comment including potential protein function from variant allele, e.g., missense or rescuing in-frame isoform

Historical ENIGMA classification2, or ClinVar classifications

Rationale for classification

Seo et al. [1]

c.1115G > A, p.(Trp372*)

c.1115G > A, p.(Trp372*)

Sibs

♀, FA, T-ALL (5y),

♀, FA, NC (8y)

Sib 1—DEB sensitive and spontaneous;

Sib 2—elevated chromosomal sensitivity to DEB and MMC

∆11q

∆11q

C5

C5

Variant alleles predicted to encode a truncated non-functional protein

Seo et al. [1]

c.1292 T > G, p.(Leu431*)

c.1292 T > G, (p.Leu431*)

Sibs:

♀, FA, NB (2y),

♂, FA, NC (15.5y)

Both sibs, DEB sensitive and spontaneous

∆11q

∆11q

C5

C5

Variant alleles predicted to encode a truncated non-functional protein

Sawyer et al. [4]

c.594_597del, p.(Ser198Argfs*35)

c.5095C > T, p.(Arg1699Trp)

♀, FA, BC (23y)

DEB and MMC sensitive

∆9–10, and 10p (r.594-21_594-1ins)

missense

n.a

C5

c.594_597del results in a truncation in BRCA1 exon 10 (de la Hoya et al. [29]), where ∆9–10 is shown to be naturally occurring isoform

c.5095C > T: IARC C5 based on posterior probability from multifactorial likelihood analysis, thresholds for class as per Plon et al. [30]. Posterior probability = 1 (Lindor et al. [31])

Domchek et al. [2]

c.2457delC, p.(Asp825Glufs*21)

c.5207 T > C, p.(Val1736Ala)

♀, FA, OC (28y)

Not tested

∆11q

missense

C5

C5

c.2457delC allele predicted to encode a truncated non-functional protein

c.5207T > C: IARC C5 based on posterior probability from multifactorial likelihood analysis, thresholds for class as per Plon et al. [30]. Posterior probability = 0.9998

Freire et al. [7]

c.2709 T > A, p.(Cys903*)

c.2709 T > A, p.(Cys903*)

♀, FA, NC (3.7y)

DEB sensitive and spontaneous

∆11q

∆11q

n.a

n.a

Variant alleles predicted to encode a truncated non-functional protein

Keupp et al. [3]

c.181 T > G, p.(Cys61Gly)

c.5096G > A, p.(Arg1699Gln)

♀, mild FA, BC (30y)

DEB‐induced chromosome fragility in patient-derived blood lymphocytes within normal range

p.(Cys61Gly)

moderate penetrance missense

C5

C5

c.181T > G IARC C5 based on posterior probability from multifactorial likelihood analysis, thresholds for class as per Plon et al. [30]. Posterior probability = 1 (Lindor et al. [31])

The c.5096G > A variant has been shown to impact function [22, 32,33,34,35]. A genetic study ([16]) reported it to be associated with reduced risk compared to another pathogenic missense substitution variant at the same residue (BRCA1 c.5095C > T p.(Arg1699Trp)). A subsequent larger genetic study including 129 families ([17]) reported HRs of 2.83 for breast cancer and 5.83 for ovarian cancer risk, and estimated the cumulative risk to age 70 to be 20% for breast cancer and 6% for ovarian cancer. This variant is considered pathogenic with reduced penetrance relative to the average BRCA1 truncating pathogenic variant

Chirita-Emandi et al. [8]

c.2933dupA, p.(Tyr978*)

c.843_846delCTCA, p.(Ser282TyrfsTer15)

♂ FA, NC (2y)

DEB and MMC sensitive

∆11q

∆11q

n.a

C5

Variant alleles predicted to encode a truncated non-functional protein

Kwong et al. [36]

c.4065_4068delTCAA, p.(Asn1355Lysfs*10)

c.5406 + 7A > G, p.?

♀, no or very subtle FA features, OC (43y), BC (44y)

No definitive diagnostic test for FA was performed due to a lack of clinical indication of FA-like features being observed

∆11q

Partial effect on splicing (not quantified)

C5

n.a. (likely benign in ClinVar

c.4065_4068delTCAA predicted to encode a truncated non-functional protein (ENIGMA Rules, Version 2.5.1, 29 June 2017)

For c.5406 + 7A > G, the authors analyzed cDNA from blood and identified cryptic splicing with deletion of 74 nucleotides from transcript and predicted frameshift. However, the RNA result was not quantitated. No other quantitative studies of the variant are available

Borlin et al. [37]

c.1116G > A, p.(Trp372*)

c.5017_5019del, p.(His1673del)

♀, FA, CNS (1y)

MMC-induced chromosomal breakage analysis in peripheral blood lymphocytes showed strongly reduced proliferation upon stimulation, but no evidence of increased chromosomal breakage

∆11q

In-frame deletion

C5

Clinvar C3, C4

c.1116G > A allele predicted to encode a truncated non-functional protein

c.5017_5019del considered pathogenic by 8/13 submitters in Clinvar

This study

c.2475delC, p.(Asp825Glufs*21)

Ex20dup

♀, no FA symptoms, LC (64y)

MMC within normal range, Lymphoblastic cell line

∆11q

no exon 20 skipping

C5

C3

c.2457delC allele predicted to encode a truncated non-functional protein

Ex20dup function similar to p.(Arg1699Gln) indicating possibly moderate penetrance. See discussion for ACMG classification

  1. 1: Only cases with at least one confirmed likely pathogenic or pathogenic variant and features of FA OR both alleles considered risk associated and not necessarily symptoms or MMC/DEB results indicating FA are included
  2. 2: Classification as per ENIGMA historical rules version 2.5.1, 29 June 2017 unless otherwise specified
  3. FA Fanconi anemia-like disorder, T-ALL T-cell Acute Lymphoblastic Leukemia, OC Ovarian Cancer, NB Neuroblastoma, BC Breast Cancer, CLL Chronic Lymphatic Leukemia, LC Lung Cancer, NC No cancer at last follow-up, CNS Central nervous system tumor FL full length transcript, Δ skipping of reference exonic sequences inclusion of reference intronic sequences, q donor shift, DEB Diepoxybutane assay, MMC Mitomycin C
  4. n.a.: variant not classified by ENIGMA